Clinical uses of Nifosept.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000818:Animals; D002908:Chronic Disease; D003556:Cystitis / Q000188:drug therapy; D004361:Drug Tolerance; D005260:Female; D005873:Giardiasis / Q000188:drug therapy; D006801:Humans; D007408:Intestinal Absorption; D007421:Intestine, Small; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008875:Middle Aged; D009582:Nitrofurantoin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011247:Pregnancy; D011702:Pyelitis / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D013607:Tablets; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014627:Vaginitis / Q000188:drug therapy; D014847:Vulvitis / Q000188:drug therapy
D013607:Tablets; D009582:Nitrofurantoin